ArticleInternational orthopaedics2015
Outcome of an ultrashort metaphyseal-fitting anatomic cementless stem in highly active obese and non-obese patients.
Article in International orthopaedics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Influence of body mass index on sagittal hip range of motion and gait speed recovery six months after total hip arthroplasty.International orthopaedics · 2019Article
- [Total hip arthroplasty in overweight osteoarthritis patients].Der Orthopade · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study was to investigate the clinical and radiographic results and complication rates after cementless total hip arthroplasty using an ultrashort femoral stem in highly active [University of California, Los Angeles (UCLA) activity level above 8 points] obese and non-obese patients.
methodsA total of 108 patients (138 hips) in the obese group [body mass index (BMI) of 30 kg/m(2) or greater] and 125 patients (168 hips) in the nonobese group (BMI of 29 kg/m(2) or less) were enrolled in the study. The mean age was 50.7 ± 11.6 years in the obese group and 48.2 ± 13.0 years in the nonobese group. The mean follow-up was 7.4 years (range six to eight years) and 7.5 years (range six to eight years), respectively.
resultsAt the final follow-up, there were no significant differences between the highly active obese and nonobese patients with regard to the mean Harris hip score (91 versus 94 points, p = 0.091), the mean Western Ontario and McMaster Universities Osteoarthritis Index (16 versus 11 points, p = 0.135) or the mean UCLA activity scores (8.7 versus 8.8 points, p = 0.400). No hip in either group had thigh pain or a revision or ceramic fracture.
conclusionsThe most striking findings in this study were the equivalent results achieved in highly active obese and nonobese patients undergoing primary cementless total hip arthroplasty using an ultrashort metaphyseal-fitting anatomic cementless femoral component.
Indexed as
Identifiers
25219774What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.